Expressed at low levels in quiescent cells. Expression rises at the G1/S phase transition.
Polycomb group (PcG) protein. Component of the PRC2 complex, which methylates 'Lys-9' (H3K9me) and 'Lys-27' (H3K27me) of histone H3, leading to transcriptional repression of the affected target gene (PubMed:15225548, PubMed:15231737, PubMed:15385962, PubMed:16618801, PubMed:17344414, PubMed:18285464, PubMed:28229514, PubMed:29499137, PubMed:31959557). The PRC2 complex may also serve as a recruiting platform for DNA methyltransferases, thereby linking two epigenetic repression systems (PubMed:12351676, PubMed:12435631, PubMed:15099518, PubMed:15225548, PubMed:15385962, PubMed:15684044, PubMed:16431907, PubMed:18086877, PubMed:18285464). Genes repressed by the PRC2 complex include HOXC8, HOXA9, MYT1 and CDKN2A (PubMed:15231737, PubMed:16618801, PubMed:17200670, PubMed:31959557).
A chromosomal aberration involving SUZ12 may be a cause of endometrial stromal tumors. Translocation t(7;17)(p15;q21) with JAZF1. The translocation generates the JAZF1-SUZ12 oncogene consisting of the N-terminus part of JAZF1 and the C-terminus part of SUZ12. It is frequently found in all cases of endometrial stromal tumors, except in endometrial stromal sarcomas, where it is rarer.
Imagawa-Matsumoto syndrome
IMMAS
An autosomal dominant syndrome characterized by generalized overgrowth, dysmorphic features, musculoskeletal abnormalities, developmental delay and intellectual disability. Some patients have genitourinary and structural brain abnormalities.
None
The disease is caused by variants affecting the gene represented in this entry.
Sumoylated, probably by PIAS2.
Belongs to the VEFS (VRN2-EMF2-FIS2-SU(Z)12) family.
Overexpressed in breast and colon cancer.
Proteins
Epigenetics
83055Da
We found 17 products in 3 categories
ab175187
Anti-SUZ12 antibody [EPR5234(N)] - ChIP Grade
ab126577
ab249844
Anti-SUZ12 antibody [EPR5234(N)] - BSA and Azide free
ab236322